MS drug Gilenya tied to brain infection
FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare
Read MoreFaulty Pharmaceutical Drugs Resources
FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare
Read More